Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD
4.280
-0.320 (-6.96%)
Sep 18, 2024, 4:00 PM EDT - Market closed
-6.96%
Market Cap 58.18M
Revenue (ttm) 51.66M
Net Income (ttm) -3.40M
Shares Out 13.59M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE 31.45
Dividend n/a
Ex-Dividend Date n/a
Volume 40,104
Open 4.640
Previous Close 4.600
Day's Range 4.280 - 4.800
52-Week Range 3.600 - 7.130
Beta 0.45
Analysts Strong Buy
Price Target 6.75 (+57.71%)
Earnings Date Sep 11, 2024

About CSBR

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Mar 25, 1986
Employees 210
Stock Exchange NASDAQ
Ticker Symbol CSBR
Full Company Profile

Financial Performance

In 2024, Champions Oncology's revenue was $50.16 million, a decrease of -6.90% compared to the previous year's $53.87 million. Losses were -$7.28 million, 36.4% more than in 2023.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for CSBR stock is "Strong Buy." The 12-month stock price forecast is $6.75, which is an increase of 57.71% from the latest price.

Price Target
$6.75
(57.71% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Conference Call September 11, 2024 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Offic...

6 days ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, toda...

7 days ago - Accesswire

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report i...

9 days ago - Accesswire

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2024 Earnings Conference Call July 18, 2024 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matthew Hewit...

2 months ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Annual Revenue of $50.2 Million HACKENSACK, NJ / ACCESSWIRE / July 18, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, today anno...

2 months ago - Accesswire

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will repor...

2 months ago - Accesswire

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with ...

3 months ago - Accesswire

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

6 months ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $12.0 Million

HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ann...

6 months ago - Accesswire

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced ...

6 months ago - Accesswire

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

HACKENSACK, NJ / ACCESSWIRE / March 6, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its f...

6 months ago - Accesswire

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Conference Call December 12, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Operator Greetings. Welcome to the Cha...

10 months ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $11.6 Million

HACKENSACK, NJ / ACCESSWIRE / December 12, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ...

10 months ago - Accesswire

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

HACKENSACK, NJ / ACCESSWIRE / December 4, 2023 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report it...

10 months ago - Accesswire

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announc...

11 months ago - Accesswire

Champions Oncology Announces the Addition of Brady Davis as President

HACKENSACK, NJ / ACCESSWIRE / October 17, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, has app...

1 year ago - Accesswire

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2024 Earnings Conference Call September 13, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matt Hew...

1 year ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $12.6 Million

HACKENSACK, NJ / ACCESSWIRE / September 13, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven ...

1 year ago - Accesswire

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

HACKENSACK, NJ / ACCESSWIRE / September 11, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmac...

1 year ago - Accesswire

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

HACKENSACK, NJ / ACCESSWIRE / August 22, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, kicks-of...

1 year ago - Accesswire

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

HACKENSACK, NJ / ACCESSWIRE / August 1, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global preclinical and clinical research services provider that offers end-to-end oncology R&D solution...

1 year ago - Accesswire

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2023 Earnings Conference Call July 24, 2023 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Officer Co...

1 year ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Record Annual Revenue of $53.9 Million HACKENSACK, NJ / ACCESSWIRE / July 24, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug disco...

1 year ago - Accesswire

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

HACKENSACK, NJ / ACCESSWIRE / July 20, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-phe...

1 year ago - Accesswire

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

HACKENSACK, NJ / ACCESSWIRE / April 17, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled research organization that is transforming drug discovery through innovative ...

1 year ago - Accesswire